ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 61 filers reported holding ONCOCYTE CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,791 | -34.9% | 24,806 | -41.0% | 0.00% | – |
Q4 2022 | $13,500 | -38.6% | 42,068 | +36.9% | 0.00% | – |
Q3 2022 | $22,000 | -88.0% | 30,722 | -13.5% | 0.00% | – |
Q1 2021 | $184,000 | +607.7% | 35,501 | +92.9% | 0.00% | – |
Q3 2020 | $26,000 | -73.5% | 18,400 | -64.2% | 0.00% | – |
Q2 2020 | $98,000 | -44.9% | 51,367 | -28.0% | 0.00% | – |
Q2 2019 | $178,000 | +278.7% | 71,342 | +496.4% | 0.00% | – |
Q1 2019 | $47,000 | – | 11,963 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |